36PEribulin demonstrate selectively high sensitivity to recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) cells and xenograft tumors. (23rd October 2018) - Kitahara, H; Kobayashi, Y; Hirai, M; Kawashiri, S; Nakamura, H